NCT04262856Phase 2Completed

Study to Evaluate Monotherapy and Combination Immunotherapies in Participants With PD-L1 Positive Non-small Cell Lung Cancer

Study sponsor: Arcus Biosciences, Inc. · RCUS

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-07-09Actual
Enrollment · participants151Actual
Source updated2026-06-15Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Primary completion date changed

Before: 5 Jun 2025. After: 9 Jul 2025.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview